{
    "title": "Indivior drug to fight opioid addiction recommended by U.S. panel",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5038383/Indivior-drug-fight-opioid-addiction-recommended-U-S-panel.html",
    "date": "2017-11-01",
    "keywords": [
        "drug",
        "percent",
        "rbp6000",
        "buprenorphine",
        "product",
        "addiction",
        "treatment",
        "week",
        "decision",
        "health",
        "dose",
        "suboxone",
        "film",
        "herrmann",
        "market",
        "cam2038",
        "clarke",
        "ben",
        "hirschler",
        "crisis",
        "approval",
        "panel",
        "company",
        "gmt",
        "wednesday",
        "news",
        "committee",
        "food",
        "administration",
        "safety",
        "fda",
        "medicine",
        "endorsement",
        "commissioner",
        "scott",
        "gottlieb",
        "agencys",
        "use",
        "methadone",
        "ingredient",
        "alternative",
        "lot",
        "habel",
        "panelist",
        "researcher",
        "kaiser",
        "permanente",
        "oakland",
        "california",
        "abuse",
        "president",
        "trump",
        "problem",
        "emergency",
        "month",
        "difference",
        "effectiveness",
        "lack",
        "benefit",
        "nalexone",
        "tongue",
        "court",
        "ruling",
        "way",
        "rival",
        "analyst",
        "max",
        "peak",
        "lund",
        "camurus",
        "braeburn",
        "forecast",
        "reporting",
        "divya",
        "grover",
        "justin",
        "varghese",
        "bengaluru",
        "editing",
        "dasgupta",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}